PMV Pharmaceuticals, Inc.PMVPNASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-51.94M
↓ 22% below average
Average (6y)
$-42.70M
Historical baseline
Range
High:$-15.63M
Low:$-71.74M
CAGR
+22.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-51.94M | +8.3% |
| 2023 | $-56.62M | +21.1% |
| 2022 | $-71.74M | -49.7% |
| 2021 | $-47.92M | -45.7% |
| 2020 | $-32.89M | -48.3% |
| 2019 | $-22.17M | -41.9% |
| 2018 | $-15.63M | - |